What does Anxo Pharmaceutical Co., Ltd. do?

Anxo Pharmaceutical Co., Ltd. (6677.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 6677.TWO's market cap?

Anxo Pharmaceutical Co., Ltd. (6677.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 6677.TWO pay a dividend?

Yes — Anxo Pharmaceutical Co., Ltd. (6677.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 6677.TWO profitable?

Anxo Pharmaceutical Co., Ltd. (6677.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

6677.TWO

Anxo Pharmaceutical Co., Ltd.

TWO·Drug Manufacturers, Specialty & Generic · Healthcare

NT$19.00NT$2.10+12.43%

Market capNT$1.06B·Aug 26 6:59 AM UTC

Price Chart

NT$19.00+NT$2.10 (+12.43%)today

−18.07%CAGR −3.91%

Select date range

FromTo

Jun 27, 2018Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)NT$0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent DividendNT$0.399

Ex-Dividend DateAug 26

Payment DateSep 13

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$878.88M

Net Income−NT$20.46M

Net Margin−2.3%

Operating Cash FlowNT$55.76M

Capital ExpendituresNT$79.97M

Free Cash Flow−NT$24.21M

Return on Equity−2.1%

Return on Invested Capital−0.7%

Net DebtNT$406.65M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 6677.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 6677.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 6677.TWO and 80,000+ other tickers.

About Anxo Pharmaceutical Co., Ltd.

Anxo Pharmaceutical Co., Ltd. functions as a specialized enterprise in the pharmaceutical sector. This company is actively involved in the research, production, and global distribution of various medicinal products, catering to both healthcare professionals and individual patients, particularly within Taiwan and across international markets. Its comprehensive product catalog features both prescription-only drugs and over-the-counter remedies, addressing a broad spectrum of therapeutic needs. These include cardiovascular health, metabolic disorders, conditions affecting the central nervous…

CEO: Linquan Yan
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: TWO
Employees: 15
Website: www.anxo.com.tw

Peers

Peers Tab

6496.TWO

Excelsior Biopharma Inc.

Cap

NT$1.2B

4127.TWO

Tien Liang BioTech Co., Ltd.

Cap

NT$4.0B

7427.TWO

Great Novel Therapeutics Biotech & Medicals

Cap

NT$4.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 6677.TWO

What does Anxo Pharmaceutical Co., Ltd. do?: Anxo Pharmaceutical Co., Ltd. (6677.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 6677.TWO's market cap?: Anxo Pharmaceutical Co., Ltd. (6677.TWO) has a market capitalization of approximately $1.06 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 6677.TWO pay a dividend?: Yes — Anxo Pharmaceutical Co., Ltd. (6677.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 6677.TWO profitable?: Anxo Pharmaceutical Co., Ltd. (6677.TWO) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.